TAK Operating Cash Flow Growth
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Operating Cash Flow Growth
TAK Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-13.49%period ending
TAK TTM Cash from Operations YoY % (-11.84% → -13.49%)
Year-over-year change
High-resolution chart · PNG
TAK operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -13.4872% | |
| -1.4899% | |
| 6.7753% | |
| 36.8889% | |
| 38.7855% | |
| 47.5802% | |
| 52.2473% | |
| -9.0239% | |
| -19.3915% | |
| -26.6909% | |
| -30.9333% | |
| -6.3308% | |
| -5.3026% | |
| -12.9951% | |
| -7.7872% | |
| 0.9222% | |
| 0.8295% | |
| 11.0961% | |
| 44.3889% | |
| 41.3854% | |
| 48.5165% | |
| 50.9411% | |
| 32.1719% | |
| 30.6207% | |
| 69.968% | |
| 103.8949% | |
| 78.7119% | |
| 67.8742% | |
| 18.919% | |
| -13.0672% | |
| -10.5756% | |
| 3.8024% | |
| 20.5515% | |
| 44.5706% | |
| 4,705.7485% | |
| 648.6322% | |
| 394.9096% | |
| 925.3148% | |
| -104.0166% | |
| -78.0679% | |
| -69.5341% | |
| -86.0336% | |
| -20.17% | |
| -17.5682% | |
| -24.272% | |
| 23.0438% | |
| 494.5323% | |
| 24,828.7526% | |
| 379.4513% | |
| 24.9831% | |
| -75.8902% | |
| -100.3284% | |
| -14.2273% | |
| -22.4068% | |
| -11.8433% |